Top 10 Breast cancer treatment startups

Updated: February 07, 2024

These startups develop new breast cancer treatments and diagnostics technologies, such as medical imaging AI, self-diagnostic gadgets, immunotherapy, genome analytics, breast tissue 3D-printing.
1
Country: Germany | Funding: $1.7B
We are developing the next generation of personalized immunotherapies to help revolutionize the treatment of people with cancer and other debilitating diseases.
2
Country: USA | Funding: $1.1B
23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards.
3
Country: USA | Funding: $256M
Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.
4
Country: Germany | Funding: $250M
GEMoaB develops universal CAR-T platform with focus on providing significantly safer and more efficacious treatments to patients who are suffering from hard-to-treat cancers and autoimmune diseases
5
Country: USA | Funding: $220M
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
6
Country: USA | Funding: $219.5M
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
7
Country: USA | Funding: $106M
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
8
Country: Canada | Funding: $100.1M
Oncolytics Biotech is developing REOLYSIN®, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that targets cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.
9
Country: USA | Funding: $95M
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
10
Country: Israel | Funding: $72M
Ayala Pharmaceuticals develops a personalized treatment for cancer.
Ad
 Advertise your startup
11
Country: Switzerland | Funding: $65.7M
NBE-Therapeutics develops next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
12
Country: USA | Funding: $65M
Actuate Therapeutics is a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis and neurodegeneration. Our work has led to some fascinating results around anti-tumor activity in the brain, pancreas, lungs, and breasts.
13
Country: USA | Funding: $57.2M
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
14
Country: UK | Funding: £36M
Azeria Therapeutics is the world’s first pioneer factor drug discovery company.
15
Country: UK | Funding: $39.8M
Around the world the incidence of cancer is growing, and with it the demand for better, faster and less expensive solutions for diagnosis and treatment. With the aim of bringing cancer care to everyone, everywhere, Endomag is developing a clinical platform that uses safe magnetic fields to power diagnostic and therapeutic devices, avoiding the safety, workflow and availability concerns of ionizing radiation.
16
Country: USA | Funding: $34.3M
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.
17
Country: UK | Funding: $22m
Kheiron Medical Technologies aims to help radiologists detect breast cancer earlier by using deep learning
18
Country: South Korea | Funding: ₩27B
Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics. It's cancer vaccine is being evaluated for breast and gastric cancer
19
Country: USA | Funding: $20M
Ithemba created a reusable, low-cost, contamination-free breast biopsy device to expand breast cancer diagnostic capability.
20
Country: USA | Funding: $18.8M
4D Path uses H&E biopsy images to unveil hidden data instantly providing biomarker profiling and stratification. Although their initial focus is on breast cancer, the company is actively working on developing products for ovarian cancer, cervical cytology, skin cancer, and, in general, around immunotherapy in various cancers.
21
Country: Australia | Funding: $17.1M
OncoRes Medical develops an imaging technology to provide intraoperative information available to breast cancer surgeons.
22
Country: Russia
BioCAD is a full-cycle drug development and manufacturing company with a world-class research and development center.
23
Country: France | Funding: €7M
Primaa develops software tools which use artificial intelligence (AI) and deep learning to assist anatomical pathologists with cancer (in particular breast cancer) and other diagnoses.
24
Country: India | Funding: $7M
Niramai uses machine learning and AI to fight against the inaccessibility of breast examinations. They use a low-cost, portable device that takes high-res thermal images, or an alternative to traditional mammography exams and may be better with early indicators, too.
25
Country: India | Funding: $6.4M
UE LifeSciences created a breast exam device that uses cold air and heat sensors to check for vascular responses, metabolic activity, and thermal symmetry between breasts. Called the NoTouch BreastScan, this works different from a mammography that tests for physical concerns like tumors.
26
Country: USA | Funding: $5.9M
Cyrcadia Health, creator of the iTbra, offers a discreet insert that goes under any bra, and empowers women to enhance their monthly breast self-exam in their own home. Their patches detect circadian temperature changes within breast tissue, and uses machine-learning algorithms to collect data and communicate it to Cyrcadia Health.
27
Country: USA | Funding: $5.4M
iSono Health develops a wearable solution to monitor breast health.
28
Country: USA
CureMetrix offers a next generation of medical image analysis for Mammography.
29
Country: Singapore | Funding: $4.1M
FathomX is a Medical Imaging AI Spin-Off for breast cancer analysis from the National University of Singapore
30
Country: USA | Funding: $3.7M
TeVido BioDevices uses the innovative process of 3D bio-printing of living human cells for use as implants or grafts targeting use in reconstructive surgery and wound care. TeVido will change the way reconstructive surgery is approached, starting by improving options for breast cancer survivors but expanding capability to others who suffer disfigurement and long to improve their self-esteem.
31
Country: UAE | Funding: $100K
Prognica is building smart screening solution for early detection of breast cancer using artificial intelligence and machine learning.
32
Country: USA | Funding: $625K
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy. The startup’s lead candidate ACXT-3102, enables effective ligand binding to deliver targeted cytotoxic payloads in patients suffering from pancreatic adenocarcinoma. Accuronix also is developing MTDCs for other types of cancers such as breast or brain cancer.
33
Country: Egypt | Funding: $255K
Dileny Technologies provides intelligent tools for women and health professionals including radiologists and physicians working in breast health and breast cancer.
34
Country: USA
GliaLab offers uses data-driven artificial intelligence to work on existing medical imaging devices. The result is faster and more intelligent breast cancer diagnoses.
35
Country: Canada
AI Talos provides AI-guided decision-making support for breast cancer screening (Thermography), enabling you to decisively confirm what you suspect, detect what you potentially missed and concentrate on questionable studies that need more attention.
36
Country: USA
Whiterabbit has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection.
37
Country: Sweden
Thermaiscan is combining AI with thermal sensors in smartphones to solve the problem with late detection of breast cancer development. The innovation is enhancing non-specialist healthcare personnel with a breast cancer pre-screening solution. It is for the first line of healthcare that has the very first contact with patients in mini clinics, primary care units and in rural areas.
38
Country: Iran
Herpir has developed a simple method to detect and discriminate Her2-positive from Her2-negative tissue samples, including breast cancer.